These results suggest that DUSP16 may have similar function in NPC, CRC, and gastric cancer in response to various chemotherapeutic agents and the level of DUSP16 could serve as a marker for sensitivity to chemotherapy in these cancers. The gene discussed is DUSP16; the disease is nasopharyngeal carcinoma.